{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T03:27:52Z","timestamp":1794972472290,"version":"4.9.1"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>This pilot study investigated the performance of C-X-C motif chemokine receptor 4 (CXCR4) molecular imaging (<jats:sup>68<\/jats:sup>Ga-pentixafor PET\/CT) in Cushing syndrome (CS) and the correlation between CXCR4 signaling interactions and glucose metabolism in adrenocorticotropin-cortisol pathway.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We retrospectively evaluated 31 patients (16 patients with CS and 15 patients with nonfunctioning pituitary or adrenal adenomas). All patients underwent <jats:sup>68<\/jats:sup>Ga-pentixafor PET\/CT, and 11 with pituitary adenoma also underwent <jats:sup>18<\/jats:sup>F-FDG PET\/CT. The diagnosis accuracy of <jats:sup>68<\/jats:sup>Ga-pentixafor PET\/CT was calculated. The correlation between radiouptake along the pituitary-adrenal axis and hormone levels was calculated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Patients with Cushing disease characterized a focal uptake in adrenocorticotropic hormone\u2013producing pituitary adenoma (ACTH-PA). In ACTH-independent CS, there was increased uptake of <jats:sup>68<\/jats:sup>Ga-pentixafor in adrenal lesions but not in the pituitary fossa. The nonfunctioning pituitary or adrenal adenomas showed negative <jats:sup>68<\/jats:sup>Ga-pentixafor signal. The one patient with metastatic ectopic ACTH syndrome had multiple <jats:sup>68<\/jats:sup>Ga-pentixafor\u2013avid lesions. Using the threshold of SUV<jats:sub>max<\/jats:sub> &gt;8.5 in the adrenal lesions, the sensitivity and specificity of <jats:sup>68<\/jats:sup>Ga-pentixafor PET\/CT to diagnose cortisol-producing adenoma were 100% and 84.9%. A cutoff SUV<jats:sub>max<\/jats:sub> value of 3.0 on <jats:sup>68<\/jats:sup>Ga-pentixafor PET\/CT had 100% sensitivity and specificity for differentiating ACTH-PA. The corresponding hormone level was significantly correlated with uptake of <jats:sup>68<\/jats:sup>Ga-pentixafor in pituitary adenoma and adrenal tissue but not with glucose metabolism.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>We have characterized the performance of <jats:sup>68<\/jats:sup>Ga-pentixafor in different subtypes of CS. <jats:sup>68<\/jats:sup>Ga-pentixafor PET\/CT is promising in the differential diagnosis of both ACTH-independent and ACTH-dependent CS. Activated CXCR4 molecular signaling along the pituitary-adrenal axis was found in patients with Cushing disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000004244","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T13:16:16Z","timestamp":1650633376000},"page":"669-676","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":54,"title":["Usefulness of 68Ga-Pentixafor PET\/CT on Diagnosis and Management of Cushing Syndrome"],"prefix":"10.1097","volume":"47","author":[{"given":"Jie","family":"Ding","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Center for Rare Diseases Research, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anli","family":"Tong","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Hacker","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Huo","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Center for Rare Diseases Research, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,4,22]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an Endocrine Society clinical practice guideline","volume":"93","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1210\/jc.2004-2527","article-title":"Cushing's syndrome due to ectopic corticotropin secretion: twenty years' experience at the national institutes of health","volume":"90","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2015-1818","article-title":"Endocrine Society. Treatment of Cushing's syndrome: an Endocrine Society clinical practice guideline","volume":"100","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"101381","DOI":"10.1016\/j.beem.2020.101381","article-title":"Cushing's syndrome: treatment and new therapeutic approaches","volume":"34","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3171\/2016.1.JNS152119","article-title":"Cushing's disease: pathobiology, diagnosis, and management","volume":"126","year":"2017","journal-title":"J Neurosurg"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/ncpendmet0324","article-title":"Mechanisms of disease: mutations of G proteins and G-protein\u2013coupled receptors in endocrine diseases","volume":"2","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.beem.2018.01.003","article-title":"Aberrant G-protein coupled hormone receptor in adrenal diseases","volume":"32","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.2009.03689.x","article-title":"Aberrant G-protein coupled receptor expression in relation to adrenocortical overfunction","volume":"73","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"bib9-20250621","first-page":"753524","article-title":"Emerging targets in pituitary adenomas: role of the CXCL12\/CXCR4-R7 system","volume":"2014","year":"2014","journal-title":"Int J Endocrinol"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1007\/s00259-020-04722-0","article-title":"Imaging CXCR4 expression in patients with suspected primary hyperaldosteronism","volume":"47","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2967\/jnumed.121.261964","article-title":"Functional characterization of adrenocortical masses in nononcological patients using [(68)Ga]-pentixafor","volume":"63","year":"2022","journal-title":"J Nucl Med"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/RLU.0000000000002946","article-title":"Intense 68Ga-pentixafor activity in aldosterone-producing adrenal adenomas","volume":"45","year":"2020","journal-title":"Clin Nucl Med"},{"key":"bib13-20250621","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2967\/jnumed.114.151647","article-title":"Biodistribution and radiation dosimetry for the chemokine receptor CXCR4-targeting probe 68Ga-pentixafor","volume":"56","year":"2015","journal-title":"J Nucl Med"},{"key":"bib14-20250621","doi-asserted-by":"crossref","first-page":"M45","DOI":"10.1530\/EJE-15-0200","article-title":"Multiple aberrant hormone receptors in Cushing's syndrome","volume":"173","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"bib15-20250621","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ejrad.2010.12.060","article-title":"Evaluation of incidentally discovered adrenal masses with PET and PET\/CT","volume":"81","year":"2012","journal-title":"Eur J Radiol"},{"key":"bib16-20250621","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ejrad.2007.10.024","article-title":"Computed tomography, magnetic resonance imaging and 11C-metomidate positron emission tomography for evaluation of adrenal incidentalomas","volume":"69","year":"2009","journal-title":"Eur J Radiol"},{"key":"bib17-20250621","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2967\/jnumed.109.064873","article-title":"131I-6beta-iodomethyl-19-norcholesterol SPECT\/CT for primary aldosteronism patients with inconclusive adrenal venous sampling and CT results","volume":"50","year":"2009","journal-title":"J Nucl Med"},{"key":"bib18-20250621","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejim.2019.08.008","article-title":"The pituitary in nuclear medicine imaging","volume":"68","year":"2019","journal-title":"Eur J Intern Med"},{"key":"bib19-20250621","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2967\/jnumed.117.191916","article-title":"PET\/MRI in the diagnosis of hormone-producing pituitary microadenoma: a prospective pilot study","volume":"59","year":"2018","journal-title":"J Nucl Med"},{"key":"bib20-20250621","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/RLU.0000000000001318","article-title":"18F-DOPA PET\/CT physiological distribution and pitfalls: experience in 215 patients","volume":"41","year":"2016","journal-title":"Clin Nucl Med"},{"key":"bib21-20250621","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1007\/s00259-021-05370-8","article-title":"Head-to-head comparison of 68Ga-DOTATATE PET\/CT and 18F-FDG PET\/CT in localizing tumors with ectopic adrenocorticotropic hormone secretion: a prospective study","volume":"48","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib22-20250621","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11102-019-00972-w","article-title":"Diagnostic utility of gallium-68\u2013somatostatin receptor PET\/CT in ectopic ACTH-secreting tumors: a systematic literature review and single-center clinical experience","volume":"22","year":"2019","journal-title":"Pituitary"},{"key":"bib23-20250621","first-page":"1646","article-title":"The desmopressin and combined CRH-desmopressin tests in the differential diagnosis of ACTH-dependent Cushing's syndrome: constraints imposed by the expression of V2 vasopressin receptors in tumors with ectopic ACTH secretion","volume":"87","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"bib24-20250621","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1007\/BF03346721","article-title":"Somatostatin receptor expression in adrenocortical tumors and effect of a new somatostatin analog SOM230 on hormone secretion in vitro and in ex vivo adrenal cells","volume":"34","year":"2011","journal-title":"J Endocrinol Invest"},{"key":"bib25-20250621","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1471-4159.1984.tb02814.x","article-title":"Aerobic glycolysis by the pituitary gland in vivo","volume":"42","year":"1984","journal-title":"J Neurochem"},{"key":"bib26-20250621","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12020-019-01944-7","article-title":"CRH stimulation improves (18)F-FDG-PET detection of pituitary adenomas in Cushing's disease","volume":"65","year":"2019","journal-title":"Endocrine"},{"key":"bib27-20250621","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","year":"2009","journal-title":"Science"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004244","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:01:31Z","timestamp":1750536091000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,22]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004244","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,22]]}}}